Atrium Innovations Inc said a group of investors, including European private equity firm Permira funds, would purchase the dietary supplements maker for about C$751.2 million.Atrium shareholders will receive C$24 in cash per share, a nearly 23 percent premium to the stock's Thursday close on the Toronto Stock Exchange.The stock, which was trading at C$24.16 on Friday morning, has 31.3 million shares outstanding according to Thomson Reuters data.Atrium, whose key brands include Garden of Life and Genestra, has said its business in Europe remains challenged due to a weak economy.
Atrium Innovations Inc. (Atrium) is a Canada-based company engaged in the development, manufacturing, and commercialization of dietary supplements endorsed by health professionals. Shares of ATB traded higher by 23.47% or $4.595/share to $24.18. In the past year, the shares have traded as low as $11.17 and as high as $19.76. On average, 46870 shares of ATB.TO exchange hands on a given day and today's volume is recorded at 1356720.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.72% or $0.27/share to $37.72. In the past year, the shares have traded as low as $27.14 and as high as $38.73. On average, 868978 shares of TRI exchange hands on a given day and today's volume is recorded at 82492.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 1.06% or $0.42/share to $39.91. In the past year, the shares have traded as low as $26.99 and as high as $40.61. On average, 943534 shares of TRI.TO exchange hands on a given day and today's volume is recorded at 62600.
Source
